SAB Biotherapeutics announces U.S. FDA grants BTD to SAB-176
In: The Fly, 2023-04-18
serialPeriodical
Zugriff:
SAB Biotherapeutics announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, to SAB-176, an investigational therapeutic, for post-exposure prophylaxis for Type A and Type [...]
Titel: |
SAB Biotherapeutics announces U.S. FDA grants BTD to SAB-176
|
---|---|
Zeitschrift: | The Fly, 2023-04-18 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|